Mechanisms of estrogen receptor-α upregulation in breast cancers.
The most critical step for initiation and progression of estrogen receptor-α (ERα)-positive breast cancers is thought to be upregulation of ERα expression. There are several factors involved in this mechanism, i.e., increased promoter activity of the ERα gene (ESR1) at the transcriptional level, ESR1 gene amplification, and diminished degradation of ERα protein through ubiquitination and proteasomal pathways. Mediating these factors, ERα protein levels seem to be controlled, although the details of the mechanism remain to be clarified. In addition, for upregulation of estrogen signaling, functional changes in its action in cancer cells originating from normal epithelial cells, i.e., estrogen stimulation, which then leads to proliferation of ERα-positive cancer cells, has been recognized, but this action has not been observed in normal epithelial cells. These alterations are therefore likely to contribute to the pathogenesis of ERα-positive breast cancers.
Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. ymiyoshi@hyo-med.ac.jp
Yasuo
Y
Miyoshi
Keiko
K
Murase
Masaru
M
Saito
Michiko
M
Imamura
Koushi
K
Oh
D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism*; D047628:Estrogen Receptor alpha / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D015854:Up-Regulation
D047628:Estrogen Receptor alpha
Mol Endocrinol. 2004 Nov;18(11):2603-15
15284335
Cancer Res. 1997 Nov 15;57(22):4987-91
9371488
Breast Cancer Res Treat. 2007 Nov;106(1):75-84
17221152
BMC Cancer. 2009 Jan 26;9:31
19171042
Am J Pathol. 2005 Aug;167(2):409-17
16049327
Curr Pharm Des. 2007;13(7):705-17
17346185
Br J Cancer. 1988 Nov;58(5):600-5
2851309
Mol Cell. 2000 Jun;5(6):939-48
10911988
Adv Exp Med Biol. 1993;330:143-53
8368130
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5794-9
17392432
J Steroid Biochem Mol Biol. 2002 Sep;82(1):7-18
12429135
Nat Genet. 2008 Jul;40(7):806-7; author reply 810-2
18583964
J Mol Med (Berl). 1998 Jun;76(7):469-79
9660165
Cancer Res. 2007 Jun 1;67(11):5513-21
17545634
Nat Genet. 2007 May;39(5):655-60
17417639
Nature. 1986 Mar 13-19;320(6058):134-9
3754034
Mol Endocrinol. 2007 Oct;21(10):2427-39
17609434
Breast Cancer. 2008;15(4):256-61
18818989
Carcinogenesis. 1997 Mar;18(3):459-64
9067542
J Clin Pathol. 2009 Jan;62(1):6-12
18794199
Cancer Res. 2007 Nov 1;67(21):10582-91
17975003
J Biol Chem. 2006 Jan 27;281(4):1978-85
16314411
EMBO J. 1999 Nov 15;18(22):6439-47
10562555